Steven Gerald Schneider, MD - Medicare General Surgery in Grand Island, NE

Steven Gerald Schneider, MD is a medicare enrolled "Surgery" physician in Grand Island, Nebraska. He went to University Of Nebraska College Of Medicine and graduated in 1994 and has 30 years of diverse experience with area of expertise as General Surgery. He is a member of the group practice Bryan Physician Network and his current practice location is 820 North Alpha, Grand Island, Nebraska. You can reach out to his office (for appointments etc.) via phone at (308) 384-7200.

Steven Gerald Schneider is licensed to practice in Nebraska (license number 21184) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1326073016.

Contact Information

Steven Gerald Schneider, MD
820 North Alpha,
Grand Island, NE 68803-3556
(308) 384-7200
(308) 384-7378



Physician's Profile

Full NameSteven Gerald Schneider
GenderMale
SpecialityGeneral Surgery
Experience30 Years
Location820 North Alpha, Grand Island, Nebraska
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Steven Gerald Schneider attended and graduated from University Of Nebraska College Of Medicine in 1994
  NPI Data:
  • NPI Number: 1326073016
  • Provider Enumeration Date: 07/11/2006
  • Last Update Date: 02/09/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 4587738828
  • Enrollment ID: I20110816000301

Medical Identifiers

Medical identifiers for Steven Gerald Schneider such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1326073016NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208600000XSurgery 21184 (Nebraska)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Howard County Medical CenterSt paul, NEHospital
Boone County Health CenterAlbion, NEHospital
Chi Health St. FrancisGrand island, NEHospital
Merrick Medical Center/litzenberg Memorial County HospitalCentral city, NEHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Bryan Physician Network7315915873194

News Archive

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

Ventas files registration statement for outstanding 3⅞% Convertible Senior Notes due 2011

Ventas, Inc. said today that, in connection with the Company's outstanding 3⅞% Convertible Senior Notes due 2011, issued in 2006, it has filed with the Securities and Exchange Commission a registration statement on Form S-3, relating to the resale, from time to time, by the selling stockholders of shares of the Company's common stock, if any, that may become issuable upon conversion of the notes.

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer and could lead to a new way to treat patients, according to a study from cancer researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center and with collaborators at the University of Pennsylvania.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Steven Gerald Schneider allows following entities to bill medicare on his behalf.
Entity NameBryan Physician Network
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1679528798
PECOS PAC ID: 7315915873
Enrollment ID: O20040922000523

News Archive

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

Ventas files registration statement for outstanding 3⅞% Convertible Senior Notes due 2011

Ventas, Inc. said today that, in connection with the Company's outstanding 3⅞% Convertible Senior Notes due 2011, issued in 2006, it has filed with the Securities and Exchange Commission a registration statement on Form S-3, relating to the resale, from time to time, by the selling stockholders of shares of the Company's common stock, if any, that may become issuable upon conversion of the notes.

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer and could lead to a new way to treat patients, according to a study from cancer researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center and with collaborators at the University of Pennsylvania.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

Read more Medical News

› Verified 2 days ago

Entity NameSurgery Group Of Grand Island
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457421471
PECOS PAC ID: 9931140688
Enrollment ID: O20050512000835

News Archive

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

Ventas files registration statement for outstanding 3⅞% Convertible Senior Notes due 2011

Ventas, Inc. said today that, in connection with the Company's outstanding 3⅞% Convertible Senior Notes due 2011, issued in 2006, it has filed with the Securities and Exchange Commission a registration statement on Form S-3, relating to the resale, from time to time, by the selling stockholders of shares of the Company's common stock, if any, that may become issuable upon conversion of the notes.

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer and could lead to a new way to treat patients, according to a study from cancer researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center and with collaborators at the University of Pennsylvania.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

Read more Medical News

› Verified 2 days ago

Entity NameLexington Regional Health Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1316016165
PECOS PAC ID: 2860415874
Enrollment ID: O20060105000221

News Archive

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

Ventas files registration statement for outstanding 3⅞% Convertible Senior Notes due 2011

Ventas, Inc. said today that, in connection with the Company's outstanding 3⅞% Convertible Senior Notes due 2011, issued in 2006, it has filed with the Securities and Exchange Commission a registration statement on Form S-3, relating to the resale, from time to time, by the selling stockholders of shares of the Company's common stock, if any, that may become issuable upon conversion of the notes.

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer and could lead to a new way to treat patients, according to a study from cancer researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center and with collaborators at the University of Pennsylvania.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

Read more Medical News

› Verified 2 days ago

Entity NameLexington Regional Health Center
Entity TypePart A Provider - Critical Access Hospital
Entity IdentifiersNPI Number: 1467417352
PECOS PAC ID: 2860415874
Enrollment ID: O20071129000331

News Archive

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

Ventas files registration statement for outstanding 3⅞% Convertible Senior Notes due 2011

Ventas, Inc. said today that, in connection with the Company's outstanding 3⅞% Convertible Senior Notes due 2011, issued in 2006, it has filed with the Securities and Exchange Commission a registration statement on Form S-3, relating to the resale, from time to time, by the selling stockholders of shares of the Company's common stock, if any, that may become issuable upon conversion of the notes.

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer and could lead to a new way to treat patients, according to a study from cancer researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center and with collaborators at the University of Pennsylvania.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Steven Gerald Schneider is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Steven Gerald Schneider, MD
P.o. Box 5226,
Grand Island, NE 68802-5226

Ph: (308) 384-7200
Steven Gerald Schneider, MD
820 North Alpha,
Grand Island, NE 68803-3556

Ph: (308) 384-7200

News Archive

Cause of severe pediatric epilepsy disorder discovered

Researchers at the University of California, San Diego School of Medicine have discovered that convulsive seizures in a form of severe epilepsy are generated, not on the brain's surface as expected, but from within the memory-forming hippocampus.

Ventas files registration statement for outstanding 3⅞% Convertible Senior Notes due 2011

Ventas, Inc. said today that, in connection with the Company's outstanding 3⅞% Convertible Senior Notes due 2011, issued in 2006, it has filed with the Securities and Exchange Commission a registration statement on Form S-3, relating to the resale, from time to time, by the selling stockholders of shares of the Company's common stock, if any, that may become issuable upon conversion of the notes.

Loss of PTHrP hormone can prevent metastases, improve survival in mice with pancreatic cancer

Lowering levels of a hormone called PTHrP can prevent metastases and improve survival in mice with pancreatic cancer and could lead to a new way to treat patients, according to a study from cancer researchers at Columbia University Vagelos College of Physicians and Surgeons and Herbert Irving Comprehensive Cancer Center and with collaborators at the University of Pennsylvania.

New target may promote development of novel therapies for chronic sinusitis

A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. The finding gives scientists a new target for developing novel therapies to treat this form of the disease, which typically resists all current treatments.

Pharming announces EUR 20 million SEDA extension with YA Global

Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that it has extended its EUR 20 million Standby Equity Distribution Agreement (SEDA) with Yorkville Advisors Global Master SPV LTD ("YA Global") as announced on April 15, 2009, by an additional EUR 10 million to EUR 30 million in total.

Read more News

› Verified 2 days ago


Surgery Doctors in Grand Island, NE

Dr. Christopher C Seip, MD
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 820 N Alpha St, Grand Island, NE 68803
Phone: 308-384-7200    Fax: 308-398-8288
Daniel Robert Cronk, MD
Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 820 N Alpha St, Grand Island, NE 68803
Phone: 308-384-7200    Fax: 308-384-7378
Dr. Zhan Li, M.D.
Surgery
Medicare: Medicare Enrolled
Practice Location: 2620 W Faidley Ave, Grand Island, NE 68803
Phone: 308-384-4600    
Dr. Michael Allen Eigenberg, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 820 N Alpha St, Grand Island, NE 68803
Phone: 308-384-7200    Fax: 308-384-7378
John David Goering, M.D.
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 820 N Alpha St, Grand Island, NE 68803
Phone: 308-384-7200    Fax: 308-384-7378
Brant Noel Luebbe, M.D
Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 820 N Alpha St, Grand Island, NE 68803
Phone: 308-384-7200    Fax: 308-384-7378

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.